Aimei Health Technology Co., Ltd.

For the period ended Mar 31, 2025. Filed May 14, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 14, 2025

AFJK$12.03-1.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item 1. Financial Statements

UNAUDITED BALANCE SHEETS

	March 31, 2025	December 31, 2024
ASSETS
Current assets:
Cash	$7,345	$28,208
Prepaid expenses	677	2,176
Total current assets	8,022	30,384
Cash held in Trust Account	43,594,825	73,784,549
TOTAL ASSETS	$43,602,847	$73,814,933
LIABILITIES, TEMPORARY EQUITY AND SHAREHOLDERS’ DEFICIT
Current liabilities:
Accrued expenses	$457,420	$299,514
Extension loan – related party	755,400	227,700
Due to a related company	472,926	289,780
Total current liabilities	1,685,746	816,994
Deferred underwriter fee payable	690,000	690,000
TOTAL LIABILITIES	2,375,746	1,506,994
Commitments and contingencies (Note 7)	-	-
Ordinary shares, subject to possible redemption. 3,995,773 and 6,900,000 shares issued and outstanding at redemption value of $10.91 and $10.69, as of March 31, 2025 and December 31, 2024, respectively	43,594,825	73,784,549
Shareholders’ deficit:
Ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 2,126,000 and 2,126,000 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively (excluding 3,995,773 and 6,900,000 shares subject to possible redemption, respectively)	213	213
Accumulated deficit	(2,367,937)	(1,476,823)
Total shareholders’ deficit	(2,367,724)	(1,476,610)
TOTAL LIABILITIES, TEMPORARY EQUITY AND SHAREHOLDERS’ DEFICIT	$43,602,847	$73,814,933

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.